274 related articles for article (PubMed ID: 24327568)
1. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
Fassina A; Cappellesso R; Simonato F; Siri M; Ventura L; Tosato F; Busund LT; Pelizzo MR; Fassan M
Cancer Cytopathol; 2014 Apr; 122(4):274-81. PubMed ID: 24327568
[TBL] [Abstract][Full Text] [Related]
2. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
[TBL] [Abstract][Full Text] [Related]
3. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
4. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
[TBL] [Abstract][Full Text] [Related]
6. Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma.
Sheu SY; Vogel E; Worm K; Grabellus F; Schwertheim S; Schmid KW
Histopathology; 2010 Apr; 56(5):632-40. PubMed ID: 20459574
[TBL] [Abstract][Full Text] [Related]
7. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Nozhat Z; Fanaei SA; Hedayati M; Azizi F
Life Sci; 2019 Apr; 223():166-173. PubMed ID: 30890403
[TBL] [Abstract][Full Text] [Related]
8. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
9. Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling.
Fassina A; Cappellesso R; Fassan M
Chest; 2011 Nov; 140(5):1305-1311. PubMed ID: 21622546
[TBL] [Abstract][Full Text] [Related]
10. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.
Pacifico F; Crescenzi E; Mellone S; Iannetti A; Porrino N; Liguoro D; Moscato F; Grieco M; Formisano S; Leonardi A
J Clin Endocrinol Metab; 2010 Mar; 95(3):1421-30. PubMed ID: 20061417
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples.
Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927
[TBL] [Abstract][Full Text] [Related]
14. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
15. The PDCD4/miR-21 pathway in medullary thyroid carcinoma.
Pennelli G; Galuppini F; Barollo S; Cavedon E; Bertazza L; Fassan M; Guzzardo V; Pelizzo MR; Rugge M; Mian C
Hum Pathol; 2015 Jan; 46(1):50-7. PubMed ID: 25316501
[TBL] [Abstract][Full Text] [Related]
16. Expression of micro-ribonucleic acids in thyroid nodules and serum to discriminate between follicular adenoma and cancer in patients with a fine needle aspiration biopsy classified as suspicious for follicular neoplasm: A preliminary study.
Świrta JS; Wątor G; Seweryn M; Kapusta P; Barczyński M; Wołkow P
Adv Clin Exp Med; 2023 Sep; 32(9):997-1007. PubMed ID: 36897102
[TBL] [Abstract][Full Text] [Related]
17. Expression of microRNAs in basal cell carcinoma.
Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of a 3-MicroRNA signature in cytological samples of small cell lung cancer.
Mancuso G; Bovio E; Rena O; Rrapaj E; Mercalli F; Veggiani C; Paganotti A; Andorno S; Boldorini R
Cancer Cytopathol; 2016 Sep; 124(9):621-9. PubMed ID: 27153322
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
Chen YT; Kitabayashi N; Zhou XK; Fahey TJ; Scognamiglio T
Mod Pathol; 2008 Sep; 21(9):1139-46. PubMed ID: 18587330
[TBL] [Abstract][Full Text] [Related]
20. Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears.
Titov SE; Ivanov MK; Demenkov PS; Katanyan GA; Kozorezova ES; Malek AV; Veryaskina YA; Zhimulev IF
BMC Cancer; 2019 Oct; 19(1):1010. PubMed ID: 31660895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
